Actively Recruiting

Phase Not Applicable
Age: 60Years - 75Years
All Genders
Healthy Volunteers
ID07057245

Effects of Daily Protein Supplementation on Brain Function in Overweight or Obese Older Adults

Led by Maastricht University Medical Center · Updated on 2025-07-09

25

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

M

Maastricht University Medical Center

Lead Sponsor

C

Cosun

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are investigating how daily protein supplementation affects brain function in overweight or obese older adults aged 60 to 75. The study focuses on comparing the effects of plant-derived and animal-derived proteins on brain insulin-sensitivity and vascular function. The goal is to see if these protein supplements can enhance cognitive performance and help regulate appetite, using advanced brain imaging techniques to measure these effects. Participants will consume protein supplements twice daily for two weeks in a randomized order. The supplements include a plant-based protein isolate (fava bean), an animal-based protein isolate (milk), and a control supplement made of cornstarch without extra protein. Each participant will receive all three interventions in separate periods to compare their effects. During the study, researchers will assess cerebral blood flow responses before and after administering intranasal insulin spray to measure brain vascular function and insulin-sensitivity using MRI. They will also evaluate cognitive performance and brain activity related to appetite. The total involvement includes baseline screening, two-week supplementation periods, and brain scans to track changes, with careful monitoring to ensure safety and adherence to the protocol.

CONDITIONS

Brief Title

Effects of Protein Supplementation on Brain Function

Who Can Participate

Age: 60Years - 75Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Men and women aged between 60 and 75 years
  • Body mass index (BMI) between 25 and 35 kg/m2 (overweight or obese)
  • Fasting plasma glucose less than 7.0 mmol/L
  • Fasting serum total cholesterol less than 8.0 mmol/L
  • Fasting serum triacylglycerol less than 4.5 mmol/L
  • Systolic blood pressure less than 160 mmHg and diastolic blood pressure less than 100 mmHg
  • Stable body weight with less than 3 kg change in the past three months
  • Willing to stop being a blood donor from 8 weeks before until 4 weeks after the study
  • No difficult venipuncture during screening visit
Not Eligible

You will not qualify if you...

  • Allergy to milk products or fava beans
  • Vegetarian diet
  • Left-handedness
  • Current smoker or quit smoking less than 12 months ago
  • Diabetes diagnosis
  • Familial hypercholesterolemia
  • Drug abuse
  • More than 3 alcoholic drinks per day
  • Use of supplements or products affecting study outcomes
  • Use of medication for blood pressure, lipids, or glucose metabolism
  • Participation in another biomedical trial within the past month
  • Severe medical conditions like epilepsy, asthma, kidney failure, COPD, inflammatory or autoimmune diseases
  • Active cardiovascular disease or recent heart attack or stroke
  • Contraindications for MRI such as pacemaker, metal implants, or claustrophobia

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 2 weeks per supplementation period

Participants consume, in random order, twice daily protein supplements consisting of a plant protein isolate, an animal protein isolate, or a control (cornstarch) during separate 2-week periods.

Multiple visits depending on crossover schedule

Trial Site Locations

Total: 1 location

1

Maastricht University Medical Center

Maastricht, Limburg, Netherlands, 6229ER

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

PREVENTION

Number of Arms

3

Similar Trials

A Randomized, Triple-blind, Placebo Controlled, Cross-over C...

Cognitive Function

Actively Recruiting

1 location

Effect of Sleep Quality on Self-Care in Patients with Heart ...

Heart Failure

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here